Here is What Hedge Funds Think About HTG Molecular Diagnostics, Inc. (HTGM)
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Htg Molecular Diagnostics Inc (HTGM)
Get Email AlertsHedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Armistice Capital Steven Boyd | 834,054 | $1,159 | 0.02% | |
| 2. | Samjo Capital Andrew N. Wiener | 404,963 | $563 | -32% | 0.48% |
| 3. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 285,963 | $397 | -15% | 0.01% |
| 4. | Renaissance Technologies Jim Simons | 55,516 | $77 | +2% | 0% |
| 5. | Millennium Management Israel Englander | 27,492 | $38 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.34 | 1,000 | Officer, Director | 11,718 | 2015-08-24 | Filing | |
| $5.16 | 1,000 | Officer | 1,356 | 2015-08-24 | Filing | |
| $5.75 | 5,800 | Officer | 6,500 | 2015-08-18 | Filing | |
| $5.83 | 100 | Officer | 700 | 2015-08-18 | Filing | |
| $5.84 | 400 | Officer | 600 | 2015-08-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.72 | 5,718 | Officer, Director | 256,121 | 2019-12-26 | Filing | |
| $2.11 | 945 | Officer | 42,303 | 2017-12-01 | Filing | |
| $2.26 | 945 | Officer | 43,248 | 2017-11-01 | Filing | |
| $2.27 | 946 | Officer | 44,193 | 2017-10-16 | Filing | |
| $1.75 | 720,214 | Large Shareholder | 0 | 2017-08-25 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 332,197 | $462 | 0.19% | |
| 2. | 245,766 | $341 | 0% | |
| 3. | 46,039 | $63 | 0% | |
| 4. | 15,811 | $22 | 0% | |
| 5. | 14,763 | $21 | 0% |
News See All
Is HTG Molecular Diagnostics, Inc. (HTGM) A Good Stock To Buy?
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter.
Do Hedge Funds Love HTG Molecular Diagnostics, Inc. (HTGM)?
In this article you are going to find out whether hedge funds think HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) is a good investment right now.
Hedge Funds Have Never Been This Bullish On HTG Molecular Diagnostics, Inc. (HTGM)
Hedge funds are known to underperform the bull markets but that's not because they are bad at investing.
13D Filing: Novo A/s and Htg Molecular Diagnostics Inc (NASDAQ:HTGM)
person has previously filed a statement on Schedule 13G to report the acquisition which is subject of this Schedule 13D, and is filing this statement because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check...
13D Filing: Glaxosmithkline Plc and Htg Molecular Diagnostics Inc (NASDAQ:HTGM)
You can access the original SEC filing by clicking here.
Today’s Trending Stocks: Sarepta, Humana, HTG Molecular Diagnostics, and More
After yesterday's rather sharp fall, Wall Street is quiet today as the Dow is up only 14 points while the NASDAQ is 0.01% in the green. In this article, we analyze some stocks that are more volatile...
Here’s Why These Five Stocks Are Gaining Ground Today
In spite of better-than-expected April retail sales data, U.S.
Billionaire Hedge Funds
